Achieve Life Sciences, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACHV research report →
About the company
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom.
- CEO
- Richard A. Stewart
- IPO
- 1995
- Employees
- 25
- HQ
- Vancouver, BC, CA
Price Chart
- Market Cap
- $657.02M
- P/E
- -5.71
- P/S
- 0.00
- P/B
- 32.00
- EV/EBITDA
- -12.66
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -193.49%
- ROIC
- -194.96%
- Revenue
- $0 · 0.00%
- Net Income
- $-54,648,000 · -37.21%
- EPS
- $-1.25 · -0.81%
- Op Income
- $-54,880,000
- FCF YoY
- -66.17%
- 52W High
- $7.11
- 52W Low
- $2.02
- 50D MA
- $5.13
- 200D MA
- $4.46
- Beta
- 2.22
- Avg Volume
- 1.95M
Get TickerSpark's AI analysis on ACHV
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 29, 26 | Waldman Reid Alexander | other | 47,250 |
| May 29, 26 | Farrow Jeffrey S | other | 47,250 |
| May 29, 26 | Waldman Reid Alexander | other | 0 |
| May 29, 26 | Farrow Jeffrey S | other | 0 |
| May 11, 26 | Martin Christopher Nathan | other | 47,250 |
| May 11, 26 | Martin Christopher Nathan | other | 0 |
| Apr 17, 26 | Royston Aaron | other | 0 |
| Apr 17, 26 | TPG GP A, LLC | other | 0 |
| Apr 17, 26 | TPG GP A, LLC | other | 6,877,580 |
| Apr 17, 26 | Iancovici Lucian | other | 0 |
Our ACHV coverage
Recent articles, reports, and earnings notes.
No research on ACHV yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ACHV report →Similar companies
Peers in the same neighborhood.